Clinical trials
Recruiting Neoplasm Metastasis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
114 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 13 |
| 2024 | 17 |
| 2025 | 27 |
| 2026 | 31 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 114 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 8 |
| Fudan University | 8 |
| Beijing Biotech | 6 |
| AstraZeneca | 4 |
| Pfizer | 4 |
| Sun Yat-sen University | 4 |
| Tianjin Medical University | 4 |
| Ming-Yuan Chen | 3 |
| Beijing Mabworks Biotech Co., Ltd. | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 114 |
| Breast Neoplasms | 22 |
| Neoplasms | 18 |
| Recurrence | 16 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Ovarian Neoplasms | 12 |
| Stomach Neoplasms | 11 |
| Colorectal Neoplasms | 10 |
| Liver Neoplasms | 9 |
| Pancreatic Neoplasms | 9 |
Trials
Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.
14 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.